Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Sell
13,600
-91,800
-87% -$7.86M ﹤0.01% 1982
2025
Q4
$9.01M Buy
+105,400
New +$8.82M 0.03% 495
2025
Q3
Sell
-2,300
Closed -$232K 2977
2025
Q2
$232K Buy
+2,300
New +$234K ﹤0.01% 1995
2024
Q4
Sell
-11,300
Closed -$1.64M 2546
2024
Q3
$1.64M Buy
11,300
+8,600
+319% +$1.17M 0.01% 965
2024
Q2
$394K Buy
+2,700
New +$379K ﹤0.01% 1398
2023
Q3
Sell
-7,300
Closed -$820K 2500
2023
Q2
$820K Buy
+7,300
New +$870K 0.01% 1072
2022
Q2
Sell
-5,200
Closed -$397K 3042
2022
Q1
$397K Buy
+5,200
New +$492K ﹤0.01% 2024

Other funds holding CROX

HRT Financial's CROX Position: Q1 2026 in Review

HRT Financial sold out of Crocs (CROX) in Q1 2026, closing a stake of 73,075 shares — an estimated $6.26M sold.

HRT Financial first reported a position in CROX in Q2 2019 and held it in 14 quarters. The position peaked at $19.1M in Q2 2023. 456 funds tracked by Wall St. Rank hold CROX as of Q1 2026.

  • HRT Financial reported no remaining Crocs position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 73,075 Crocs shares in Q1 2026, an estimated $6.26M.
  • HRT Financial first reported a position in Crocs in Q2 2019 and held it in 14 quarters.
  • HRT Financial's Crocs position peaked at $19.1M in Q2 2023.
  • 456 funds tracked by Wall St. Rank held Crocs as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.